We advise U.S. and global companies expanding into the European Union on regulatory positioning, institutional engagement, and long-term market strategy.

Operating from Amsterdam, we provide strategic guidance at the intersection of EU regulation, trade policy, and political risk.

Our work includes:

• EU regulatory landscape assessment

• European Commission and Parliament engagement strategy

• Technology and digital governance advisory

• Healthcare and pharmaceutical policy environment analysis

• Trade, tariff, and supply chain exposure review

• Cross-border regulatory alignment strategy

• Policy risk advisory for cross-border growth and investment decisions

For companies entering Europe, regulatory timing, political momentum, and enforcement posture can materially affect market access, valuation, and expansion strategy. We help leadership teams anticipate these variables before capital is deployed or operations scale.

We provide strategic regulatory and government affairs advisory services. We do not practice Dutch or EU law.